This paper proposes an immersive training system for patients with hand dysfunction who can perform rehabilitation training independently. The system uses Leap Motion binocular vision sensors to collect human hand inf...This paper proposes an immersive training system for patients with hand dysfunction who can perform rehabilitation training independently. The system uses Leap Motion binocular vision sensors to collect human hand information, and uses the improved PCA<sub><img src="Edit_d6662636-9073-4fbd-855f-9a36e871d5a4.png" width="10" height="15" alt="" /></sub> (Principal Component Analysis) to perform data fusion on the real-time data collected by the sensor to obtain more hands with fewer principal components, and improve the stability and accuracy of the data. Immediately, the use of improved SVM<sub><img src="Edit_10c78725-e09e-4dcf-ae05-e21205df4acc.png" width="10" height="15" alt="" /></sub> (Support Vector Machine) and KNN<sub><img src="Edit_0ee97f55-2773-4b48-93b3-93f61aa25577.png" width="10" height="15" alt="" /></sub> (K-Nearest Neighbor Algorithm) for gesture recognition and classification is proposed to enable patients to perform rehabilitation training more effectively. Finally, the effective evaluation results of the rehabilitation effect of patients by the idea of AHP<sub><img src="Edit_70dd1964-28be-4137-afa5-9a184704f08e.png" width="10" height="15" alt="" /></sub> (Analytic Hierarchy Process) are taken as necessary reference factors for doctors to follow up treatment. Various experimental results show that the system has achieved the expected results and has a good application prospect.展开更多
目的系统评价稳心颗粒联合美托洛尔治疗冠心病心律失常的有效性及安全性。方法通过计算机检索中国知网、万方数据库、维普信息资源系统、PubMed、Web of Science及Cochrane Library等数据库,时间为建库至2019年6月,收集有关稳心颗粒联...目的系统评价稳心颗粒联合美托洛尔治疗冠心病心律失常的有效性及安全性。方法通过计算机检索中国知网、万方数据库、维普信息资源系统、PubMed、Web of Science及Cochrane Library等数据库,时间为建库至2019年6月,收集有关稳心颗粒联合美托洛尔治疗冠心病心律失常的临床随机对照试验。由两位评价员对纳入的研究进行资料提取和质量评价,并采用RevMan 5.3软件进行统计学分析。结果纳入的32篇研究共3383例病人。Meta分析结果显示,稳心颗粒联合美托洛尔治疗冠心病心律失常在临床总有效率[RR=1.21,95%CI(1.18,1.25),P<0.00001]、室性期前收缩次数[SMD=-4.40,95%CI(-5.64,-3.17),P<0.00001]、房性期前收缩次数[SMD=-4.27,95%CI(-5.78,-2.77),P<0.00001]、ST段压低程度[MD=-0.36,95%CI(-0.41,-0.31),P<0.00001]、ST段压低持续时间[MD=-0.73,95%CI(-0.82,-0.65),P<0.00001]、不良反应发生率[RR=0.69,95%CI(0.55,0.87),P=0.002]方面,均优于单用美托洛尔,差异均有统计学意义。结论当前证据表明,与单用美托洛尔比较,稳心颗粒联合美托洛尔治疗冠心病心律失常,可提高临床疗效,并且安全性更佳。展开更多
文摘This paper proposes an immersive training system for patients with hand dysfunction who can perform rehabilitation training independently. The system uses Leap Motion binocular vision sensors to collect human hand information, and uses the improved PCA<sub><img src="Edit_d6662636-9073-4fbd-855f-9a36e871d5a4.png" width="10" height="15" alt="" /></sub> (Principal Component Analysis) to perform data fusion on the real-time data collected by the sensor to obtain more hands with fewer principal components, and improve the stability and accuracy of the data. Immediately, the use of improved SVM<sub><img src="Edit_10c78725-e09e-4dcf-ae05-e21205df4acc.png" width="10" height="15" alt="" /></sub> (Support Vector Machine) and KNN<sub><img src="Edit_0ee97f55-2773-4b48-93b3-93f61aa25577.png" width="10" height="15" alt="" /></sub> (K-Nearest Neighbor Algorithm) for gesture recognition and classification is proposed to enable patients to perform rehabilitation training more effectively. Finally, the effective evaluation results of the rehabilitation effect of patients by the idea of AHP<sub><img src="Edit_70dd1964-28be-4137-afa5-9a184704f08e.png" width="10" height="15" alt="" /></sub> (Analytic Hierarchy Process) are taken as necessary reference factors for doctors to follow up treatment. Various experimental results show that the system has achieved the expected results and has a good application prospect.
文摘目的系统评价稳心颗粒联合美托洛尔治疗冠心病心律失常的有效性及安全性。方法通过计算机检索中国知网、万方数据库、维普信息资源系统、PubMed、Web of Science及Cochrane Library等数据库,时间为建库至2019年6月,收集有关稳心颗粒联合美托洛尔治疗冠心病心律失常的临床随机对照试验。由两位评价员对纳入的研究进行资料提取和质量评价,并采用RevMan 5.3软件进行统计学分析。结果纳入的32篇研究共3383例病人。Meta分析结果显示,稳心颗粒联合美托洛尔治疗冠心病心律失常在临床总有效率[RR=1.21,95%CI(1.18,1.25),P<0.00001]、室性期前收缩次数[SMD=-4.40,95%CI(-5.64,-3.17),P<0.00001]、房性期前收缩次数[SMD=-4.27,95%CI(-5.78,-2.77),P<0.00001]、ST段压低程度[MD=-0.36,95%CI(-0.41,-0.31),P<0.00001]、ST段压低持续时间[MD=-0.73,95%CI(-0.82,-0.65),P<0.00001]、不良反应发生率[RR=0.69,95%CI(0.55,0.87),P=0.002]方面,均优于单用美托洛尔,差异均有统计学意义。结论当前证据表明,与单用美托洛尔比较,稳心颗粒联合美托洛尔治疗冠心病心律失常,可提高临床疗效,并且安全性更佳。